v3.26.1
Note 10 - Stock-based Compensation (Tables)
6 Months Ended
Jun. 30, 2026
Notes Tables  
Share-Based Payment Arrangement, Option, Activity [Table Text Block]

 

 

Number of Stock Options

 

 

Weighted Average Exercise Price

 

 

Remaining Contractual Term (Years)

 

 

Intrinsic Value(2)

 

Outstanding stock options at December 31, 2025

 

 

45,834

 

 

$

354.62

 

 

 

6.6

 

 

$

 

Granted(1)

 

 

68,084

 

 

$

9.27

 

 

 

 

 

 

 

 

 

Exercised

 

 

 

 

$

 

 

 

 

 

 

 

 

 

Forfeited

 

 

(3,076

)

 

$

1,326.36

 

 

 

 

 

 

 

 

 

Outstanding stock options at June 30, 2026(3)

 

 

110,842

 

 

$

115.53

 

 

 

8.6

 

 

$

2

 

Vested and exercisable stock options at June 30, 2026

 

 

33,576

 

 

$

355.18

 

 

 

6.5

 

 

$

 

Nonvested Restricted Stock Shares Activity [Table Text Block]

 

 

Number of Restricted Stock Awards

 

 

Weighted Average Grant Date Fair Value

 

Unvested restricted stock awards as of December 31, 2025

 

 

67,739

 

 

$

58.27

 

Granted

 

 

935,650

 

 

 

9.83

 

Vested

 

 

(68

)

 

 

173.92

 

Forfeited

 

 

 

 

 

 

Unvested restricted stock awards as of June 30, 2026

 

 

1,003,321

 

 

$

13.09

 

Share-Based Payment Arrangement, Cost by Plan [Table Text Block]

 

 

Three Months Ended

 

 

Six Months Ended

 

 

 

June 30,

 

 

June 30,

 

 

 

2026

 

 

2025

 

 

2026

 

 

2025

 

Sales and marketing expenses

 

$

8

 

 

$

1

 

 

 

13

 

 

 

46

 

General and administrative expenses

 

 

874

 

 

 

148

 

 

 

1,029

 

 

 

944

 

Research and development expenses

 

 

35

 

 

 

13

 

 

 

57

 

 

 

102

 

Total stock-based compensation expense

 

$

917

 

 

$

162

 

 

$

1,099

 

 

$

1,092

 

Share-Based Payment Arrangement, Unrecognized Compensation Expense [Table Text Block]

 

 

Unrecognized Expense

 

 

Weighted Average Remaining Service Period (Years)

 

PAVmed 2014 Equity Plan

 

 

 

 

 

 

Stock Options

 

$

579

 

 

 

2.3

 

Restricted Stock Awards

 

$

9,097

 

 

 

2.8

 

Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]

Six Months Ended

June 30,

2026

2025

Expected term of stock options (in years)

5.8

5.8

Expected stock price volatility

104

%

101

%

Risk free interest rate

3.90

%

3.90

%

Expected dividend yield

0

%

0

%